Karolinska University Hospital Solna

Solna 17164

0 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Anal Carcinoma, Basal Cell Carcinoma (Unresectable or Metastatic), Cervical Cancer, Clear Cell Ovarian or Endometrial Carcinoma, Cutaneous Squamous Cell Carcinoma, Cyclin-dependent Kinase 12 Mutated Tumors, DNA Polymerase Epsilon Mutated Tumors (P286R and V411L), Esophageal Squamous Cell Carcinoma, Follicular Lymphoma, MSI-H/dMMR Tumors, Marginal Zone Lymphoma

Studies at this site

• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors — Stopped early